NHL All-Star Ryan Getzlaf and CureDuchenne Raise $750,000 at 11th Annual Getzlaf Golf Shootout

NHL All-Star Ryan Getzlaf Joins Forces with Global Nonprofit to Help Find a Cure for Duchenne Muscular Dystrophy

NEWPORT BEACH, Calif., (September 20, 2022) – CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy, partnered with Stanley Cup-winning, NHL All-Star and retired Anaheim Ducks captain Ryan Getzlaf for the 11th Annual Getzlaf Golf Shootout. Held on September 9th and 10^th at Monarch Beach Golf Links, the event raised more than $750,000 to support CureDuchenne. The Getzlaf Golf Shootout, hosted by Ryan and Paige Getzlaf, brought together professional athletes, celebrities, and community leaders for a two-day experience. The event featured an MVP Dinner reception on Friday evening followed by an action-packed day of activities and golf at the beautiful Monarch Beach Golf Links in Dana Point, California.

“When Paige and I partnered with CureDuchenne to start this tournament 11 years ago, we had no idea what it could become and the impact it could make on this community. We are truly humbled by the support we receive year after year,” said Ryan Getzlaf. “We are closer to a cure for this devastating disease than ever before and know that together, we will find a cure.”

NHL All-Star and 2007 Stanley Cup Champion Ryan Getzlaf played a remarkable 17-year career for the Anaheim Ducks, holding the record as the franchise’s all-time leading scorer and serving as team captain for the last 11 years. Over the past 11 years, Ryan and Paige have raised more than $5.3 million to fund early-stage research and bring new therapies for boys and their families dealing with Duchenne muscular dystrophy.

Duchenne muscular dystrophy, the most common and severe form of muscular dystrophy, is a fatal genetic disease affecting roughly 1 in 5,000 male births. Individuals with Duchenne are typically diagnosed as toddlers, lose the ability to walk in their early-teens and often succumb to the disease in their mid-20s. Since CureDuchenne was created in 2003, the organization has raised over $50 million for research and to develop impactful programs that help families living with Duchenne and has funded 16 research projects that have advanced to human clinical trials.

“The ongoing dedication and support of the Getzlaf family is vital in helping us get closer to a cure for thousands of people with Duchenne muscular dystrophy,” said Debra Miller, founder and CEO of CureDuchenne. “We are eternally grateful to the Getzlafs, our generous community, ​​donors and athletes who support the Getzlaf Golf Shootout. Every dollar raised and invested into cutting-edge research moves us closer to a cure. Now more than ever, hope for a cure is on the horizon.”

The event kicked off with select sponsors and Anaheim Ducks players attending an MVP dinner with live auction. The golf tournament took place the following day, starting with a breakfast for families living with Duchenne. Golfers were greeted by LA Rams Cheerleaders and Ducks Power Players before enjoying a round of golf with contests, games and giveaways throughout the course, including a dunk tank and hole-in-one opportunities to win a Porsche.

This year’s sponsors included Eydie and David MacInnis, Porsche, FR Construction, F & F Capital Group, Roger Dunn Golf Hawaii, WHGC P.L.C., Air Control Systems, Duke Spirits, As One Cru, OC Raw, Ameriprise Financial, PMG, TaylorMade, Independent Capital Management, Inc., The Sports Corporation, Central Coast Disc Golf, Wayne Farms, Engels Janzen, Ayres Hotels, Ayres Construction Company, TSG Wealth Management, Brewery X, Realtor Heidi Stoops, Tito’s Handmade Vodka, Lava, California Love Drop, Tap Truck, CaliFino Tequila, Entertainment Concepts, The Long Drink, TransUnited Financial Services, Inc., Krank Golf, Violent Gentlemen, Glaceau Smartwater, Anuva Capital and Khalil Law Group.

For more information about CureDuchenne, please visit www.cureduchenne.org.

About CureDuchenne
CureDuchenne is recognized as a global leader in research, patient care and innovation for improving and extending the lives of those with Duchenne muscular dystrophy. As the leading genetic killer of young boys, Duchenne affects more than 300,000 individuals living today. CureDuchenne is dedicated to finding and funding a cure for Duchenne by breaking the traditional charitable mold through an innovative venture philanthropy model that funds groundbreaking research, early diagnosis, and community education. For more information on how to help raise awareness and funds needed for research, please visit www.cureduchenne.org.